Cipla gains on getting approval from USFDA for Ambrisentan Tablets

02 May 2019 Evaluate

Cipla is currently trading at Rs. 567.25, up by 3.00 points or 0.53% from its previous closing of Rs. 564.25 on the BSE.

The scrip opened at Rs. 561.10 and has touched a high and low of Rs. 567.90 and Rs. 557.00 respectively. So far 22639 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 678.00 on 19-Sep-2018 and a 52 week low of Rs. 483.75 on 29-Jan-2019.

Last one week high and low of the scrip stood at Rs. 572.65 and Rs. 551.25 respectively. The current market cap of the company is Rs. 45550.44 crore.

The promoters holding in the company stood at 36.70%, while Institutions and Non-Institutions held 40.81% and 22.49% respectively.

Cipla and its subsidiary Cipla USA, Inc., have received final approval for the Abbreviated New Drug Application (ANDA) for Ambrisentan Tablets 5mg & 10mg from the United States Food and Drug Administration (USFDA).

The company’s Ambrisentan Tablets 5mg & 10mg is AB-rated generic therapeutic equivalent version of Gilead Sciences, Inc.’s Letairis. Ambrisentan tablet is an endothelin receptor antagonist indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability and delay clinical worsening. The US Sales of Letairis Tablets USP stood at $943 million in 2018. The product is available for shipping immediately.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. The company’s portfolio includes over 1500 products across wide range of therapeutic categories with one quality standard globally.

Cipla Share Price

1505.05 8.70 (0.58%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×